Antegenes is an innovative Estonian medical laboratory and technology company founded in 2018. Their mission is to enable people to live better, healthier, and longer lives by helping individuals, healthcare professionals, and organisations use genetic information for personal and public health.
Everything Genetic is proud to be investors in Antegenes and exclusive UK distributors.
Antegenes develop and implement advanced genetic tests based on polygenic risk scores technology for cancer and other complex diseases to enable personalised prevention measures and programs. They have brought four innovative CE-IVD marked genetic tests into clinical use for breast cancer, prostate cancer, colorectal cancer, and skin melanoma, plus two combined genetic tests for men and women. Their genetic tests are created scientifically with laboratory and clinical validity and utility to ensure they can be used by a broad range of healthcare professionals and institutions.
Learn more about Antegenes.
Antegenes’ tests offered through Everything Genetic include: